Excited to present today at prestigious Late-Breaking Science forum at the @escardio#HeartFailure2022, first clinical data of the VECTOR-HF I study which confirms the safety and accuracy of V-LAP in heart microcomputer for remote management of #HeartFailure@OranKoren@DDamario
In a great presentation and discussion today at #europcr2022, Dr. Eyal Orion, MD discussed how Vectorious is transforming #heartfailure treatment paradigms by allowing patients to remotely monitor their LA pressure via the V-LAP app and take ownership of their disease
Pleasure to be part of #InnovationDublin22! Earlier today Eyal Orion, MD presented the VECTOR-HF II study and how our unique patient self-management approach empowers #heartfailure patients to take control of their disease and improves #patientcare!
@MedTechStrat
We've enrolled the first 6 patients in the VECTOR-HF II Study! These #heartfailure patients will have full visibility of their hearts’ LA pressure via the V-LAP app & can self-adjust their medication to stop further deterioration & avoid hospitalizations. https://t.co/naMffy8J1I
For the first time in two years, #InnovationDublin22, Europe's largest #medtech partnering and investment conference is back! If you're nearby come hear the latest developments in the VECTOR-HF study! Thursday 28, 2022 09:15-09:25 @MedTechStrat
Excited to attend the first-ever Technology and Heart Failure Therapeutics ( #THT2022) meeting in NYC and present the ongoing development of our clinical data about the role of personalized LAP management in #heartfailure patients using the V-LAP system.
#WorldHeartDay reminds us that #cardiovascular diseases (CVDs) are still the #1 killer among adults worldwide.
With a joint effort of the medical community, entrepreneurs, tech companies, and scientists, will we succeed in eradicating the greatest epidemic in the world.
Amazing news for Vectorious' V-LAP and for all FDA's #Breakthroughdevices and a HUGE WIN for the millions of patients around the world that will soon have faster access to the latest #medicaldevices innovations!
https://t.co/R9JqtaenFk
@CMSGov@FDADeviceInfo
A case study by #Vivnates team which demonstrates the V-LAP's value in treating and stabilizing a German #heartfailure patient remotely, while in self-isolation during the #COVID19.
Reamote healthcare is no longer a privilege. It's here to stay.
https://t.co/MmQWzLUf8I @ehj_ed
Exciting day for Vectorious!
A vote of confidence by the @US_FDA in the V-LAP potential to significantly upgrade #heartfailure management and treatment and the clear benefits of left atrial pressure (LAP)-based therapy!
https://t.co/Aoexy4fSBG
Congratulations to the team at @rambam_hospital Haifa, Israel, on their 1st implantation of the V-LAP, the world’s first in-heart microcomputer. Proud to be on this exciting journey together and setting new standards for #heartfailure management and treatment!
The @MailOnline takes a look at the inventions that are changing the face of cardiac care, including our V-LAP, the world's first in-heart microcomputer for remote monitoring of #heartfailure patients.
https://t.co/b0CDWsKQTc
Great to see our name as of one of "10 health tech startups shaping the future of healthcare in the UK" by @Maddyness_UK@Audrey151290
https://t.co/nFHnC9gYBN
Can you improve the quality of life for a person who lives with severe #heartfailure in under 60 minutes?
Yes!
Earlier today we performed another successful implantation of the world's first in-heart microcomputer, at Rabin Medical Center. #remotepatientmonitoring#Medicaldevices
What medical devices are going to transform #heartfailure treatment and become the #standardofcare by 2030?
Join @CSIcongress coming webinar to make sure you catch the leading voices in this world, including our very own @LeorPerl, Vectorious' medical director.
CSI Webinars: Device Based Heart Failure Treatment - The Next Frontier
Join us on August 12th, 2020 at 16.00 CEST with Horst Sievert, @drnvanmieghem, Stefan Bertog, @FudimMarat, William Abraham, Markus Reinartz, @nicolasdumonte1 and @LeorPerl
Register: https://t.co/XmAUMAsyhl